Our inventions change the world and the reinvented world then changes us. Behind conflict and cooperation lies the question of risk responsibility. Whose duty is it in today’s complex societies to foresee the potentially negative impacts of disruptive technologies such as gene-editing? Do we possess the necessary tools and instruments for forecasting and preventing harm?
|
Thomas LANDRAIN
|
Co-Founder and President, Just One Giant Lab; Co-Founder and ex Chief Executive Officer, PILI and La Paillasse, Paris | | | |
|
|
Jenny MOLLOY
|
Coordinator, OpenPlant & SynBio SRI, University of Cambridge | | | |
|
|
Lalitha SUNDARAM
|
Post-Doctoral Research Associate, CSER - Centre for the Study of Existential Risk, University of Cambridge | | | |
|
|
Rüdiger TROJOK
|
Scientific Staff, ITAS - Institute for Technology Assessment and Systems Analysis, KIT - Karlsruhe Institute for Technology, Berlin | | | |
|
|
Eleonore PAUWELS
|
Senior Program Associate, Director of Biology Collectives Project, Woodrow Wilson International Center for Scholars, Washington, D.C. | |
Chair | |
|
Co-Founder and President, Just One Giant Lab; Co-Founder and ex Chief Executive Officer, PILI and La Paillasse, Paris
| 2002-2005 | Licence (B.Sc.), Molecular Biology and Physiology, Institut catholique d’etudes superieures |
| 2005-2007 | Master, Biology - Genetics, Universite Paris Diderot |
| Master, Biology - Genetics, ENS - Ecole normale superieure |
| 2007-2008 | Master, Interdisciplinary Approach to Life Sciences, Universite Denis Diderot (Paris VII) |
| 2009-2014 | Doctor of Philosophy - PhD, Synthetic Biology, Universite Paris-Saclay |
| since 2014 | Mentor, IndieBio |
| since 2017 | Member of the Digital Strategy Board, APHP, Paris |
| Co-Founder and Board Member, La Paillasse, Paris |
| Co-Founder and President, Just One Giant Lab, Paris |
Coordinator, OpenPlant & SynBio SRI, University of Cambridge
| 2010-2015 | DPhil Zoology, University of Oxford |
| since 2015 | Coordinator, OpenPlant and Synthetic Biology Strategic Research Initiative, University of Cambridge |
| since 2016 | Director, ContentMine Ltd. |
| Director, Biomakespace Ltd., Cambridge |
Post-Doctoral Research Associate, CSER - Centre for the Study of Existential Risk, University of Cambridge
| 2012-2014 | Senior Laboratory Technician, Department of Pathology, University of Cambridge |
| 2014-2016 | Research Associate, Arsenic Biosensor Collaboration, Department of Pathology, University of Cambridge |
| 2016-2017 | Post-Doctoral Research Fellow, Emerging Biotechnologies and Global Health, Department of Global Health and Social Medicine, King's College London |
| 2017 | PhD, Department of Pathology, University of Cambridge; PhD Viva: Provisional Pass, subject to corrections |
| since 2017 | Post-Doctoral Research Associate, Bio-Risk, Centre for the Studiy of Existential Risk, University of Cambridge |
Scientific Staff, ITAS - Institute for Technology Assessment and Systems Analysis, KIT - Karlsruhe Institute for Technology, Berlin
Senior Program Associate, Director of Biology Collectives Project, Woodrow Wilson International Center for Scholars, Washington, D.C.
| 2005-2006 | United Nation Development Program (UNDP), Democratic Governance Group, Brussels |
| 2006-2008 | European Commission, Directorate-General for Research, Unit Governance and Ethics— Ethics Review/National Experts, Brussels |
| 2008-2013 | Woodrow Wilson International Center for Scholars, Science and Technology Innovation Program (STIP) - Public Policy Scholar, Washington, D.C. |
| since 2013 | Woodrow Wilson International Center for Scholars, Science and Technology Innovation Program (STIP) - Director of Biology Collectives, Washington, D.C. |
| Co-PI, SYNENERGENE (321488, FP7), EU Project on Responsible Innovation in Genomics |
| since 2017 | IEEE Committee Member on Artificial Intelligence |
| Research Associate with the AI Initiative, The Future Society, Harvard Kennedy School, Cambridge, MA |
